Aprea Therapeutics, Inc. (APRE)
Cash Conversion Ratio
1.05×
Fiscal year · Period ending:
APRE Cash Conversion Ratio
Latest reported1.05×period ending
Latest reported1.05×period ending
APRE FY Cash Conversion Ratio (0.86× → 1.05×)
Latest values, visible window
High-resolution chart · PNG
APRE cash conversion ratio history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash Conversion Ratio |
|---|---|
| 1.0473× | |
| 0.8589× |